Skip to main content
MS-DRG 828 · MDC 17 · Surgical

MS-DRG 828: Myeloproliferative Disorders or Poorly Differentiated Neoplasms with Major O.R. Procedures without CC/MCC

Reviewed by QuickIntell RCM Editorial Team · Last reviewed

Data effective
Data currency: IPPS Table 5 FY2027 final rule (effective October 1, 2026); Definitions Manual v44 (effective October 1, 2026). Next CMS release: April 1, 2027 (v44.1 mid-year update), then the FY2028 final rule in August 2027.

Key facts for DRG 828

FY2027 relative weight
1.6950
Higher than 52% of all MS-DRGs
Change vs FY2026
-0.5%
FY2026 weight 1.7040
Geometric mean LOS
2.2 days
Arithmetic mean 2.7 days
MDC
17
Myeloproliferative Diseases and Disorders, Poorly Differentiated Neoplasms
Severity level
without CC or MCC
Transfer policy
Not a transfer DRG

TL;DR

MS-DRG 828 is a surgical group in MDC 17 (Myeloproliferative Diseases and Disorders, Poorly Differentiated Neoplasms) at the base severity level of its family. CMS assigns it a FY2027 relative weight of 1.6950 with a geometric mean length of stay of 2.2 days and an arithmetic mean of 2.7. Its weight moved down 0.5% from FY2026 (1.7040). That weight is higher than 52% of all surgical and medical MS-DRGs. Its CC/MCC family (DRG 826, DRG 827) spans weights 1.6950 to 4.7560. The v44 Definitions Manual assigns it through 114 principal diagnosis codes and 4536 operating room procedures codes.

What changed from FY2026 to FY2027

CMS recalibrates every MS-DRG weight annually from the prior year's MedPAR claims. For DRG 828 the FY2027 relative weight is 1.6950 against 1.7040 in FY2026, a fall of 0.53%.

FY2026 versus FY2027 payment factors for MS-DRG 828
MetricFY2026FY2027Change
Relative weight1.70401.6950-0.0090
Geometric mean LOS (days)2.42.2-0.2
Arithmetic mean LOS (days)2.92.7-0.2
Weights shown are the FY2027 final values after the 10% cap on year-over-year reductions where applicable.

CC and MCC family

DRG 828 shares its base definition with 2 other MS-DRGs split by severity. The family's weights span 1.6950 to 4.7560, a 2.81× spread, which is the payment effect of documenting qualifying complications and comorbidities.

MS-DRGs in the same base group as DRG 828
DRGTitleFY2027 weightGMLOS
826Myeloproliferative Disorders or Poorly Differentiated Neoplasms with Major O.R. Procedures with MCC4.75608.8
827Myeloproliferative Disorders or Poorly Differentiated Neoplasms with Major O.R. Procedures with CC2.38903.9
828Myeloproliferative Disorders or Poorly Differentiated Neoplasms with Major O.R. Procedures without CC/MCC1.69502.2

Grouper logic (v44 Definitions Manual)

Principal Diagnosis: 114 ICD-10 codes drive assignment to this group; the first 12 are shown.

Principal Diagnosis codes assigned to DRG 828 (sample)
ICD-10 codeDescription
C37Malignant neoplasm of thymus
C457Mesothelioma of other sites
C459Mesothelioma, unspecified
C480Malignant neoplasm of retroperitoneum
C7640Malignant neoplasm of unspecified upper limb
C7641Malignant neoplasm of right upper limb
C7642Malignant neoplasm of left upper limb
C7650Malignant neoplasm of unspecified lower limb
C7651Malignant neoplasm of right lower limb
C7652Malignant neoplasm of left lower limb
C768Malignant neoplasm of other specified ill-defined sites
C7983Secondary malignant neoplasm of oral cavity

Operating Room Procedures: 4536 ICD-10 codes drive assignment to this group; the first 12 are shown.

Operating Room Procedures codes assigned to DRG 828 (sample)
ICD-10 codeDescription
0016070Bypass Cerebral Ventricle to Nasopharynx with Autologous Tissue Substitute, Open Approach
0016071Bypass Cerebral Ventricle to Mastoid Sinus with Autologous Tissue Substitute, Open Approach
0016072Bypass Cerebral Ventricle to Atrium with Autologous Tissue Substitute, Open Approach
0016073Bypass Cerebral Ventricle to Blood Vessel with Autologous Tissue Substitute, Open Approach
0016074Bypass Cerebral Ventricle to Pleural Cavity with Autologous Tissue Substitute, Open Approach
0016075Bypass Cerebral Ventricle to Intestine with Autologous Tissue Substitute, Open Approach
0016076Bypass Cerebral Ventricle to Peritoneal Cavity with Autologous Tissue Substitute, Open Approach
0016077Bypass Cerebral Ventricle to Urinary Tract with Autologous Tissue Substitute, Open Approach
0016078Bypass Cerebral Ventricle to Bone Marrow with Autologous Tissue Substitute, Open Approach
001607ABypass Cerebral Ventricle to Subgaleal Space with Autologous Tissue Substitute, Open Approach
001607BBypass Cerebral Ventricle to Cerebral Cisterns with Autologous Tissue Substitute, Open Approach
00160J0Bypass Cerebral Ventricle to Nasopharynx with Synthetic Substitute, Open Approach

Documentation and denial exposure

As a surgical DRG, assignment depends on a qualifying operating-room procedure being coded from the operative report; a missing or non-OR procedure code drops the stay into a medical DRG in MDC 17 with a lower weight. Because this family splits by severity, auditors target CC and MCC capture: each secondary diagnosis must be documented as present, monitored, evaluated or treated during the stay to survive a DRG-validation review. Typical inpatient denial codes for this group: CARC 16 (claim lacks information needed to group the stay), CARC 50 (the admission or procedure is judged not medically necessary), CARC 97 (a service is bundled into the DRG payment).

How QuickIntell uses DRG 828 data

QuickCode groups inpatient encounters against the current v44 logic, flags CC and MCC candidates that lack supporting documentation, and shows the weight difference across the family before the claim drops. QuickScribe captures the attending's language that supports severity, and QuickRCM works DRG-validation denials with the grouper evidence attached.

Frequently asked questions — DRG 828

What is MS-DRG 828?

MS-DRG 828 is "Myeloproliferative Disorders or Poorly Differentiated Neoplasms with Major O.R. Procedures without CC/MCC", a surgical Medicare Severity Diagnosis-Related Group in MDC 17, Myeloproliferative Diseases and Disorders, Poorly Differentiated Neoplasms. Medicare pays inpatient stays grouped here at the hospital's base rate multiplied by the DRG relative weight.

What is the FY2027 relative weight for DRG 828?

The FY2027 relative weight is 1.6950 (IPPS final rule Table 5, effective October 1, 2026). In FY2026 it was 1.7040, a change of -0.5%.

What is the average length of stay for DRG 828?

CMS reports a geometric mean length of stay of 2.2 days and an arithmetic mean of 2.7 days for FY2027. The geometric mean is used for transfer-payment calculations.

Which DRGs are in the same CC/MCC family as 828?

DRG 826 (Myeloproliferative Disorders or Poorly Differentiated Neoplasms with Major O.R. Procedures with MCC, weight 4.7560); DRG 827 (Myeloproliferative Disorders or Poorly Differentiated Neoplasms with Major O.R. Procedures with CC, weight 2.3890). The family's weights range from 1.6950 to 4.7560, so documented complications and comorbidities change payment materially.

What documentation supports the severity level of DRG 828?

DRG 828 is the base-severity assignment: no secondary diagnosis on the CC or MCC lists was coded, or the only ones present are excluded for this principal diagnosis. Revenue-integrity review here looks for undercapture, meaning conditions treated during the stay (electrolyte disorders, specified anemia, acute blood loss, pressure injuries present on admission) that were never documented to the specificity the lists require. A compliant query to the attending, not a coder assumption, is the only way to move a stay to the CC or MCC sibling.

Which codes group to DRG 828?

The v44 Definitions Manual lists 114 principal diagnosis codes and 4536 operating room procedures codes for this group. Examples from the principal diagnosis list: C37 (Malignant neoplasm of thymus); C457 (Mesothelioma of other sites); C459 (Mesothelioma, unspecified); C480 (Malignant neoplasm of retroperitoneum).

Is DRG 828 a post-acute transfer DRG?

No. DRG 828 is not on the FY2027 post-acute care transfer list, so the transfer per-diem policy does not apply to it.

Sources

Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-10-01. Verify against the primary file before billing or contracting decisions.

Disclaimer

This page is an operational reference compiled from the CMS IPPS FY2027 final rule (Table 5) and the v44 ICD-10 MS-DRG Definitions Manual. Relative weights are national factors; actual payment depends on each hospital's wage-adjusted base rate, add-ons, outliers and transfer adjustments. Nothing here is legal, clinical or billing advice; verify grouping against your encoder and the published CMS files.